This favorable MMRd tumor response to ICB is probably due to high immune infiltration in the tumor microenvironment (TME), likely driven by multiple mechanisms, including a high neoantigen load and the activation of the cGAS-cGAMP-STING pathway (33–35) (Figure 2). This evidence concerns the gene CGAS and neoplasm.